{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:49:50Z","timestamp":1791593390109,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T00:00:00Z","timestamp":1619481600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NFR-2017R1C1B5017278"],"award-info":[{"award-number":["NFR-2017R1C1B5017278"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.semarthrit.2021.04.011","type":"journal-article","created":{"date-parts":[[2021,4,25]],"date-time":"2021-04-25T22:09:54Z","timestamp":1619388594000},"page":"677-684","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Global patterns of treat-to-serum urate target care for gout: Systematic review and meta-analysis"],"prefix":"10.1016","volume":"51","author":[{"given":"Chang-Nam","family":"Son","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borislav","family":"Mihov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Gamble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Dalbeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.semarthrit.2021.04.011_bib0001","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41572-019-0115-y","volume":"5","author":"Dalbeth","year":"2019","journal-title":"Gout Nat Rev Dis Primers"},{"key":"10.1016\/j.semarthrit.2021.04.011_bib0002","first-page":"2020","article-title":"Prevalence, incidence, and years lived with disability due to gout and its attributable risk factors for 195 countries and territories 1990-2017: a systematic analysis of the global burden of disease study","author":"Safiri","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"10.1016\/j.semarthrit.2021.04.011_bib0003","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1002\/art.40929","article-title":"Effects of allopurinol dose escalation on bone erosion and urate volume in gout: a dual-energy computed tomography imaging study within a randomized","volume":"71","author":"Dalbeth","year":"2019","journal-title":"Control Trial Arthritis Rheumatol."},{"issue":"12","key":"10.1016\/j.semarthrit.2021.04.011_bib0004","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1002\/art.40233","article-title":"Effects of febuxostat in early gout: a randomized, double-blind, placebo-controlled study","volume":"69","author":"Dalbeth","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2021.04.011_bib0005","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1002\/art.40159","article-title":"Lesinurad, a selective uric acid reabsorption inhibitor, in combination with febuxostat in patients with tophaceous gout: findings of a phase III clinical trial","volume":"69","author":"Dalbeth","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"10156","key":"10.1016\/j.semarthrit.2021.04.011_bib0006","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(18)32158-5","article-title":"Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial","volume":"392","author":"Doherty","year":"2018","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.semarthrit.2021.04.011_bib0007","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/art.41247","article-title":"2020 American college of rheumatology guideline for the management of gout","volume":"72","author":"FitzGerald","year":"2020","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2021.04.011_bib0008","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","article-title":"2016 updated EULAR evidence-based recommendations for the management of gout","volume":"76","author":"Richette","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"20","key":"10.1016\/j.semarthrit.2021.04.011_bib0009","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.4103\/0366-6999.216416","article-title":"Chinese multidisciplinary expert consensus on the diagnosis and treatment of hyperuricemia and related diseases","volume":"130","year":"2017","journal-title":"Chin Med J"},{"key":"10.1016\/j.semarthrit.2021.04.011_bib0010","doi-asserted-by":"crossref","DOI":"10.1002\/acr2.11199","article-title":"Patient perspectives on gout and gout treatments: a patient panel discussion that informed the 2020 American college of rheumatology treatment guideline","author":"Singh","year":"2020","journal-title":"ACR Open Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2021.04.011_bib0011","first-page":"575","article-title":"Nurse-led care is preferred over GP-led care of gout and improves gout outcomes: results of Nottingham Gout Treatment Trial follow-up study","volume":"59","author":"Fuller","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.semarthrit.2021.04.011_bib0012","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1136\/annrheumdis-2013-203325","article-title":"Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative","volume":"73","author":"Sivera","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.semarthrit.2021.04.011_bib0013","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/RHU.0000000000000621","article-title":"Utility of electronic medical records in community rheumatology practice for assessing quality of care indicators for gout: a feasibility study","volume":"24","author":"Estrada","year":"2018","journal-title":"J Clin Rheumatol"},{"issue":"1404","key":"10.1016\/j.semarthrit.2021.04.011_bib0014","first-page":"37","article-title":"Variation in gout care in Aotearoa New Zealand: a national analysis of quality markers","volume":"127","author":"Jackson","year":"2014","journal-title":"N Z Med J"},{"issue":"9","key":"10.1016\/j.semarthrit.2021.04.011_bib0015","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00296-017-3777-3","article-title":"Quality of care in gout: a clinical audit on treating to the target with urate lowering therapy in real-world gout patients","volume":"37","author":"Janssen","year":"2017","journal-title":"Rheumatol Int"},{"issue":"9","key":"10.1016\/j.semarthrit.2021.04.011_bib0016","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.3899\/jrheum.150310","article-title":"An observational study of gout prevalence and quality of care in a national australian general practice population","volume":"42","author":"Robinson","year":"2015","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2021.04.011_bib0017","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/art.22767","article-title":"Quality of care for gout in the US needs improvement","volume":"57","author":"Singh","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.semarthrit.2021.04.011_bib0018","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/acr.23500","article-title":"Development of the American college of rheumatology electronic clinical quality measures for gout","volume":"70","author":"FitzGerald","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.semarthrit.2021.04.011_bib0019","first-page":"339","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","author":"Liberati","year":"2009","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.semarthrit.2021.04.011_bib0020","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","article-title":"2016 updated EULAR evidence-based recommendations for the management of gout","volume":"76","author":"Richette","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2021.04.011_bib0021","series-title":"Study quality assessment tools","year":"2021"},{"key":"10.1016\/j.semarthrit.2021.04.011_bib0022","series-title":"Cochrane handbook for systematic reviews of interventions. The cochrane collaboration","author":"Higgins","year":"2011"},{"issue":"2","key":"10.1016\/j.semarthrit.2021.04.011_bib0023","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jrsm.12","article-title":"A basic introduction to fixed-effect and random-effects models for meta-analysis","volume":"1","author":"Borenstein","year":"2010","journal-title":"Res Synth Methods"},{"issue":"2","key":"10.1016\/j.semarthrit.2021.04.011_bib0024","doi-asserted-by":"crossref","first-page":"e122","DOI":"10.1016\/S2665-9913(19)30004-9","article-title":"Making the right thing the easy thing to do: strategies to improve outcomes in gout","volume":"1","author":"Dalbeth","year":"2019","journal-title":"Lancet Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2021.04.011_bib0025","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1136\/annrheumdis-2012-201676","article-title":"Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational study","volume":"72","author":"Rees","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.semarthrit.2021.04.011_bib0026","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.3899\/jrheum.150310","article-title":"An observational study of gout prevalence and quality of care in a national australian general practice population","volume":"42","author":"Robinson","year":"2015","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.semarthrit.2021.04.011_bib0027","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1185\/03007990903017966","article-title":"Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis","volume":"25","author":"Halpern","year":"2009","journal-title":"Curr Med Res Opin"},{"issue":"11","key":"10.1016\/j.semarthrit.2021.04.011_bib0028","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jclinepi.2010.08.010","article-title":"Conducting quantitative synthesis when comparing medical interventions: AHRQ and the effective health care program","volume":"64","author":"Fu","year":"2011","journal-title":"J Clin Epidemiol"}],"updated-by":[{"DOI":"10.1016\/j.semarthrit.2021.12.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000}}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017221000664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017221000664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T17:20:18Z","timestamp":1635528018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017221000664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0049017221000664"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2021.04.011","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.semarthrit.2021.12.001","asserted-by":"object"}]},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global patterns of treat-to-serum urate target care for gout: Systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2021.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}